Meranda Parascandola - DSI InPharmatics

October 7, 2021

Published by Meranda Parascandola at October 7, 2021

Avoiding and Addressing Surprises in the API Manufacturing Process

When you’re developing and manufacturing your active pharmaceutical ingredients, the last thing you want to deal with is surprises. Unfortunately, even with the soundest methods, processes, and strategies, problems occur in manufacturing.

November 1, 2021

Published by Meranda Parascandola at November 1, 2021

Microbiological Quality Considerations in Non-Sterile Drug Manufacturing

Mike Carroll, Quality Professional and Aseptic Processing specialist has an extensive history in microbiology and pharmaceuticals. One of his most recent commentaries is on Microbiological Quality Considerations in Non-Sterile Drug Manufacturing, a draft of guidance published in September of 2021

November 4, 2021

Published by Meranda Parascandola at November 4, 2021

How To Tell A Compelling CMC Story In Your NDA/BLA Application

Storytelling is integral to the pharmaceutical regulatory process. It’s really what your new drug application (NDA) or biologics license application (BLA) is all about. It’s about deciphering the data to tell a reviewer how your process and product works.

November 18, 2021

Published by Meranda Parascandola at November 18, 2021

The Do’s And Don’ts of Selecting A Contract Manufacturer

As any pharmaceutical company knows, most drugs don’t make it into the clinic so the medical chemistry process early on involves just a few kilograms of product. But if all goes well, and the drug makes it into the clinic, suddenly the quantities become metric tons or more, and the manufacturing and safety processes become quite different.

December 1, 2021

Published by Meranda Parascandola at December 1, 2021

DSI Announces Virtual Attendance of Biotech Showcase 2022, January 10-19

Each year, healthcare, pharmaceutical, and biotechnology executives attend the JP Morgan Healthcare Conference, some to tout recent developments, others just to bounce from session to session. We work hard at DSI to make life science companies better at what you do in the Chemistry, Manufacturing and Controls (CMC) areas. We’ve […]

January 19, 2022

Published by Meranda Parascandola at January 19, 2022

The Pros and Cons of Outsourcing Manufacturing to China

Trust is important when selecting a contract manufacturing organization (CMO), particularly when offshoring. With more biopharmaceutical companies looking to China-based CMOs, companies need to understand both the opportunities and the challenges the market presents.